TRIPLET
Phase 2/3 Completed
229 enrolled
Intensified Chemotherapy in CRC After Resection of Liver Metastases
Phase 2/3 Completed
124 enrolled
Perioperative Intravenous Lidocaine in Liver Surgery
Phase 2/3 Completed
124 enrolled
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Phase 2/3 Completed
201 enrolled
MAHOGANY
Phase 2/3 Completed
82 enrolled 22 charts
NICE
Phase 2/3 Completed
104 enrolled
MOUNTAINEER-02
Phase 2/3 Completed
17 enrolled 23 charts
PACHA-01
Phase 2/3 Completed
104 enrolled
POWERRANGER
Phase 2/3 Completed
29 enrolled
Study of ONO-4538 in Gastric Cancer
Phase 2/3 Completed
680 enrolled
CHANGE
Phase 2/3 Completed
270 enrolled
GEP-NOC
Phase 2/3 Completed
18 enrolled
A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer
Phase 2/3 Completed
1,000 enrolled
RAMSES/FLOT7
Phase 2/3 Completed
180 enrolled
SATURNE
Phase 2/3 Completed
78 enrolled 9 charts
AMEBICA
Phase 2/3 Completed
191 enrolled
A-C
Phase 2/3 Completed
169 enrolled
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
Phase 2/3 Completed
52 enrolled
TreeTopp
Phase 2/3 Completed
151 enrolled 18 charts
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
Phase 2/3 Completed
40 enrolled
CATIQ
Phase 2/3 Completed
64 enrolled 7 charts
PARECEC
Phase 2/3 Completed
135 enrolled
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
Phase 2/3 Completed
219 enrolled
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Phase 2/3 Completed
116 enrolled
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma
Phase 2/3 Completed
40 enrolled
PETRARCA
Phase 2/3 Completed
81 enrolled
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
Phase 2/3 Completed
350 enrolled
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2/3 Completed
492 enrolled
Aspirin/Folate Prevention of Large Bowel Polyps
Phase 2/3 Completed
1,121 enrolled
CONCORDE
Phase 2/3 Completed
196 enrolled
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Phase 2/3 Completed
716 enrolled
CRC009
Phase 2/3 Completed
512 enrolled
Bioinformation Therapy for Gastric Cancer
Phase 2/3 Completed
120 enrolled
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
Phase 2/3 Completed
58 enrolled
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Phase 2/3 Completed
90 enrolled
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
Phase 2/3 Completed
86 enrolled
BIOBAR
Phase 2/3 Completed
208 enrolled
START
Phase 2/3 Completed
90 enrolled
HBV-DNA(-)
Phase 2/3 Completed
200 enrolled
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
Phase 2/3 Completed
54 enrolled
HORIZON III
Phase 2/3 Completed
1,814 enrolled 13 charts
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
Phase 2/3 Completed
583 enrolled
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
Phase 2/3 Completed
71 enrolled
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Phase 2/3 Completed
34 enrolled
Prospective Study Comparing EUS vs ERCP Stent Insertion for Malignant Biliary Obstruction
Phase 2/3 Completed
30 enrolled
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
Phase 2/3 Completed
120 enrolled
SHVE
Phase 2/3 Completed
132 enrolled
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Phase 2/3 Completed
100 enrolled
The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors
Phase 2/3 Completed
52 enrolled
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Phase 2/3 Completed
10,838 enrolled